A Narrative Review on Multidimensional Modelling of Psychosis and Depression: Integrating In-vivo, Genetic and Computational Approaches
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Psychiatric illnesses such as psychosis and depression profoundly affect individuals’ functioning, quality of life and overall health. Psychosis most notably schizophrenia- afflicts approximately 0.3-0.7% of the global population and is associated with severe disability, cognitive decline and increased premature mortality. Major Depressive Disorder (MDD) is even more prevalent, affecting nearly one in four individuals worldwide. Despite their clinical differences, both conditions share dysregulated neurotransmitter pathways involving dopamine, serotonin and noradrenaline. Current treatments, including antipsychotics and antidepressants, offer only partial relief, with many patients experiencing delayed therapeutic onset, adverse effects, treatment resistance, or suboptimal response. These limitations underscore the urgent need for improved mechanistic understanding and more effective therapeutic strategies. The present review examines the contribution of preclinical in-vivo models to the study of the pathogenesis and treatment of psychosis and depression. Widely used behavioural paradigms such as the Open Field Test (OFT), prepulse inhibition, catalepsy bar test, amphetamine or apomorphine-induced stereotypy and Phencyclidine (PCP)-induced locomotor activity are evaluated for their ability to mimic key symptom domains. Genetic models, including the G72/G30 transgenic mouse and the extrapyramidalprimed monkey model, offer insights into gene-behaviour associations and the neurobiological underpinnings of antipsychotic side-effects. Complementing these, computational approaches such as Temporal Difference (TD) learning models provide systemslevel perspectives on dopaminergic prediction errors and behavioural adaptation. The review highlights the pressing need for multidimensional, integrative frameworks that bridge molecular, behavioural, genetic and computational domains. Advancing such comprehensive models will improve translational relevance, enable identification of novel therapeutic targets and support the development of more precise and effective treatments for psychosis and depression.
Fields of Study & Subjects
Schizophrenia research and treatment
Neurotransmitter Receptor Influence on Behavior
Tryptophan and brain disorders
Publication details
- Journal / source
- JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
- Publication date
- 28 March 2026
- Language
- EN